Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues
Sabrina Porta(A. O. Ordine Mauriziano di Torino), Guillermo Ruiz‐Irastorza(BioCruces Health research Institute), Ãlvaro Danza(Universidad de la República de Uruguay), Adriana Carlomagno(Universidad de la República de Uruguay), Florencia Vivero(Hospital Privado de Comunidad), Maira Arias Saavedra(Hospital Ramos Mejía), María Cecilia Goizueta
Cited by 100
Related Papers
A Randomized Trial of Intravenous Amino Acids for Kidney Protection
|New England Journal of Medicine|2024|178
Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts
|Autoimmunity Reviews|2017|85
Note of Republication: A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires
|Clinical Pharmacology & Therapeutics|2017|71
A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery
|New England Journal of Medicine|2025|34
Adipokines, Cardiovascular Risk, and Therapeutic Management in Obesity and Psoriatic Arthritis
|Frontiers in Immunology|2021|32